EXPERIMENTAL ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE
Article Sidebar
Main Article Content
Аннотация:
In recent years, a significant increase in the prevalence of non-alcoholic fatty liver disease (NAFLD) has been observed among various population groups, including adolescents and young adults. This trend has made NAFLD a pressing public health problem. The liver plays a central role in regulating metabolic processes in the human body, and its dysfunction negatively affects multiple organ systems, including the cardiovascular and endocrine systems. Effective treatment of NAFLD largely depends on a clear understanding of its pathogenetic mechanisms. Experimental models are of particular importance in studying these mechanisms and in developing rational preventive and therapeutic strategies.
Article Details
Как цитировать:
Библиографические ссылки:
Babak O.Ya., Kolesnikova E.V. Pathogenetic mechanisms of non-alcoholic fatty liver disease: focus on the clinical application of ademetionine. Suchasna Gastroenterology. 2011;59(3):56–63.
Bivalkevich N.V., Karaman Yu.K. Experimental substantiation of fucoidan as a hepatoprotective agent in non-alcoholic fatty liver disease. Pacific Medical Journal. 2012;47(1):41–43.
Zvenigorodskaya L.A., Egorova E.G. Liver damage in insulin resistance. Experimental and Clinical Gastroenterology. 2007;(1):20–24.
Karaman Yu.K., Novgorodtseva T.P., Bivalkevich N.V., et al. Regulatory role of nitric oxide and carbon monoxide in oxidative stress during experimental dyslipidemia. Russian Journal of Physiology. 2010;96(5):529–538.